1 / 57

METAL CATALYZED ASYMMETRIC REDUCTION

For more presentations and information visit http://www.pharmaxchange.info. METAL CATALYZED ASYMMETRIC REDUCTION. For references please read abstract at http://pharmaxchange.info/presentations/mcar.html. For more presentations and information visit http://www.pharmaxchange.info.

adrienne
Download Presentation

METAL CATALYZED ASYMMETRIC REDUCTION

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. For more presentations and information visit http://www.pharmaxchange.info METAL CATALYZED ASYMMETRIC REDUCTION For references please read abstract at http://pharmaxchange.info/presentations/mcar.html

  2. For more presentations and information visit http://www.pharmaxchange.info What is asymmetric synthesis? Chemical synthesis of a pure enantiomer, or of an enantiomorphic mixture in which one enantiomer predominates, without the use of resolution.

  3. For more presentations and information visit http://www.pharmaxchange.info Three approaches to asymmetric synthesis • Chiral pool synthesis • Chiralauxillaries • Asymmetric catalysis

  4. For more presentations and information visit http://www.pharmaxchange.info ASYMMETRIC CATALYSIS Small amounts of chiral, enantiomerically pure (or enriched) catalysts promote reactions and lead to the formation of large amounts of enantiomerically pure or enriched products. Eg : Wilkinson’s Catalyst

  5. For more presentations and information visit http://www.pharmaxchange.info THREE DIFFERENT KINDS OF CHIRAL CATALYST MOSTLY USED

  6. For more presentations and information visit http://www.pharmaxchange.info

  7. For more presentations and information visit http://www.pharmaxchange.info

  8. For more presentations and information visit http://www.pharmaxchange.info IRIDIUM CATALYZED ASYMMETRIC HYDROGENATION OF UNFUNCTIONALIZED ALKENES

  9. For more presentations and information visit http://www.pharmaxchange.info Iridium based catalysts Iridium based catalysts are one of the most important homogeneous chiral catalysts for hydrogenation of hindered unfunctionalized alkenes .

  10. For more presentations and information visit http://www.pharmaxchange.info ADVANTAGES OVER OTHER CATALYSTS • They do not require the presence of a coordinating group near the C=C bond, so even purely alkyl-substituted olefins can be hydrogenated with high enantioselectivity. • High activity in hydrogenation of hindered tetra-substituted alkenes also. • Comparitively cheaper by weight as compared to other metals like Rh. • Air and moisture stable.

  11. For more presentations and information visit http://www.pharmaxchange.info HYDROGENATION OF TWO ALKENES USING1. Rh(PPh3)2(NBD).CB11H6Br52. Ir(Py)(PCy3)(Cod).PF6

  12. For more presentations and information visit http://www.pharmaxchange.info

  13. For more presentations and information visit http://www.pharmaxchange.info DIFFERENT Ir CATALYSTS Crabtree’s catalyst Ir(COD)L1L2 . PF6

  14. For more presentations and information visit http://www.pharmaxchange.info

  15. For more presentations and information visit http://www.pharmaxchange.info CHIRAL LIGANDS

  16. For more presentations and information visit http://www.pharmaxchange.info N,P - LIGAND

  17. For more presentations and information visit http://www.pharmaxchange.info Phosphino-oxazoline (PHOX) Ligands R - tBu CH2tBu iPr Ar - o-Tol Cy Ph

  18. For more presentations and information visit http://www.pharmaxchange.info Phosphinite-oxazolineLigands Ar = Ph R1 = Ph o-Tol R2,3 = Bu R = tBu Ar = Ph, Cy iPr

  19. For more presentations and information visit http://www.pharmaxchange.info Phosphine – ThiazoleLigand

  20. For more presentations and information visit http://www.pharmaxchange.info COMPARISON BETWEEN LIGANDS

  21. For more presentations and information visit http://www.pharmaxchange.info C,N-Ligands Electron-rich N-heterocyclic carbenes based on imidazolylidenes, imidazolinylidenes and 1,2,4-triazolylidiene have emerged as useful ligands. Complexes containing these carbeneligands are more thermostable than their phosphine analogues.

  22. For more presentations and information visit http://www.pharmaxchange.info EXAMPLES

  23. For more presentations and information visit http://www.pharmaxchange.info ALKENES AS SUBSTRATES

  24. For more presentations and information visit http://www.pharmaxchange.info FUNCTIONALIZED AND UNFUNCTIONALIZED ALKENES UnfunctionalizedFunctionalized R = Alkyl CFG= Coordinating functional group CJKKLHJHH R1-3 = alkyl CFG = coordinating functional group

  25. For more presentations and information visit http://www.pharmaxchange.info Ir-Mediated Hydrogenation of Trisubstituted alkenes

  26. For more presentations and information visit http://www.pharmaxchange.info HYDROGENATION OF TRISUBSTITUTED ALKENES

  27. For more presentations and information visit http://www.pharmaxchange.info Hydrogenation of Heteroaromatic alkenes

  28. For more presentations and information visit http://www.pharmaxchange.info Hydrogenation of 1,1-disubstituted alkenes

  29. For more presentations and information visit http://www.pharmaxchange.info • So far only 2-Aryl-1-butenes and allylic alcohols have been tested using Ir complxes as catalysts. • Being less hindered as compared to trisubstituted, conversions are excellent. • However enantioselectivity varies substrate to substrate. conv 99% ee 88%

  30. For more presentations and information visit http://www.pharmaxchange.info TETRASUBSTITUTED ALKENES

  31. For more presentations and information visit http://www.pharmaxchange.info

  32. For more presentations and information visit http://www.pharmaxchange.info PHOSPHANYL - OXAZOLINE LIGANDS 99% conversion 95% ee 99% conversion 96% ee

  33. For more presentations and information visit http://www.pharmaxchange.info Mechanism Considerations for Asymmetric Ir-Mediated Hydrogenations

  34. For more presentations and information visit http://www.pharmaxchange.info Different attempts to elucidate the mechanisms of asymmetric Ir-mediated hydrogenation via theoretical methods: • Brandt group • Hall group • Chen group • Pfaltz group

  35. For more presentations and information visit http://www.pharmaxchange.info MIGRATORY INSERTION A migratory insertion reaction is when a cisoidal anionic and neutral ligand on a metal complex couple together to generate a new coordinated anionic ligand.

  36. For more presentations and information visit http://www.pharmaxchange.info OXIDATIVE ADDITION • In oxidative addition, a metal complex with vacant coordination sites and a relatively low oxidation state is oxidized by the insertion of the metal into a covalent bond(X-Y). two new anionic ligands

  37. For more presentations and information visit http://www.pharmaxchange.info STEP 1

  38. For more presentations and information visit http://www.pharmaxchange.info STEP 2

  39. For more presentations and information visit http://www.pharmaxchange.info STEP 3

  40. For more presentations and information visit http://www.pharmaxchange.info STEP 4

  41. For more presentations and information visit http://www.pharmaxchange.info STEP 5

  42. For more presentations and information visit http://www.pharmaxchange.info STEP 6 STEP 1

  43. For more presentations and information visit http://www.pharmaxchange.info

  44. For more presentations and information visit http://www.pharmaxchange.info MECHANISTIC OVERVIEW

  45. For more presentations and information visit http://www.pharmaxchange.info ENANTIOFACE SELECTIVITY MODEL Generalized iridium (III) dihydride complex with bound olefin (left), and a view of the sterics about iridium from the perspective of the olefin ligand (right). R1 = smallest olefin substituent; NR= chiral N-containing ligand (frequently oxazoline); YXn = strong trans-influence ligand (phosphine, carbene, etc.); Z =H2 or solvent.

  46. For more presentations and information visit http://www.pharmaxchange.info Schematic representation of electronically neutral trisubstituted olefin coordination to the catalyst.

  47. For more presentations and information visit http://www.pharmaxchange.info SELECTIVITY MODEL APPLIED TO DIPHENYL PROPENE

  48. For more presentations and information visit http://www.pharmaxchange.info

  49. For more presentations and information visit http://www.pharmaxchange.info EFFECT OF DIFFERENT REACTION CONDITIONS

  50. For more presentations and information visit http://www.pharmaxchange.info COUNTER ION EFFECT • Counter ion of cationic Iridium complex plays a crucial role in catalytic cycle. • Halides and weakly coordinating group triflate were found to completely deactivate the catalyst. • The PF6- salt exhibits a high reactivity with fast initial rates, however suffers from deactivation at low catalyst loading. • Bulky lipophilic anion BArf-prevents catalyst deactivation and gives high rate and full conversion even at low catalyst loading.

More Related